A Rare Case of AML-M1 with Positive Cup-Like Blast Cell
Clinical Laboratory
|July 15, 2025
Summary
Cup-like blast (CLB) cells in acute myeloid leukemia (AML) may indicate specific gene mutations. This study explores the diagnostic value of CLB cells for AML with NPM1 or FLT3-ITD mutations.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute myeloid leukemia (AML) is a stem cell malignancy.
- Morphological classification, including the presence of cup-like blast (CLB) cells, is crucial for AML diagnosis.
- CLB cells are associated with NPM1 or FLT3-ITD gene mutations.
Observation:
- A patient presented with high white blood cell count (176.33 x 10^9/L) and 80% blasts.
- Bone marrow examination revealed significant blast hyperplasia, suggesting AML-M1 morphology.
- Visible CLB cells prompted recommendations for FLT3-ITD and NPM1 gene mutation testing.
Findings:
- The study investigated the correlation between CLB cells and FLT3-ITD/NPM1 gene mutations in AML.
- CLB cells were observed in a patient with suspected AML-M1.
- Gene mutation testing was recommended based on CLB cell presence.
Implications:
- CLB cells may serve as a valuable diagnostic indicator in AML.
- Identifying CLB cells can guide further genetic testing for targeted therapy.
- Understanding CLB cell association aids in AML diagnosis and treatment strategies.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.2K
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
4.3K
